Pharmacists, Attys Navigate Murky COVID Vaccine Waters
In recent years, the changing of the season has sent millions of Americans to their local pharmacists for a COVID-19 vaccine with few worries about availability. This year, things aren't so simple. Without a complete federal roadmap, pharmacists are facing new legal uncertainties.
Evernorth Health Plugs $3.5B Into Shields Health Solutions
Evernorth Health Services, led by Wachtell Lipton Rosen & Katz and Holland & Knight LLP, on Tuesday unveiled plans to plug $3.5 billion into specialty pharmacy management company Shields Health Solutions.
Test Results At Bedtime? States Pause Patient Access
Patients getting notified of pathology reports at bedtime or at a family wedding? Texas has joined a small number of states that allow for delays in sharing sensitive results so doctors have a chance to share medical news.
Pharmacists, Attys Navigate Murky COVID Vaccine Waters
In recent years, the changing of the season has sent millions of Americans to their local pharmacists for a COVID-19 vaccine with few worries about availability. This year, things aren't so simple. Without a complete federal roadmap, pharmacists are facing new legal uncertainties.
Evernorth Health Plugs $3.5B Into Shields Health Solutions
Evernorth Health Services, led by Wachtell Lipton Rosen & Katz and Holland & Knight LLP, on Tuesday unveiled plans to plug $3.5 billion into specialty pharmacy management company Shields Health Solutions.
Test Results At Bedtime? States Pause Patient Access
Patients getting notified of pathology reports at bedtime or at a family wedding? Texas has joined a small number of states that allow for delays in sharing sensitive results so doctors have a chance to share medical news.
Expert Analysis
The Trump administration's recent artificial intelligence action plan significantly expands federal commitments ac... (more story)
A recent decision to allow the U.S. Drug Enforcement Administration to reclassify two research psychedelics in Sch... (more story)
While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent l... (more story)
Deals & Corporate Governance More
An attorney for Rex Medical butted heads with a Federal Circuit judge Tuesday over what a lower court actually did when it reduced a $10 million patent infringement verdict against Intuitive Surgical Inc. to $... (more story)
A Gilead Sciences Inc. competitor has agreed not to sell a generic version of Gilead's human immunodeficiency virus treatment Biktarvy until a trio of patents expire, according to a proposal by the parties to ... (more story)
A state court judge has pared down claims against a North Carolina doctor in a messy legal dispute with his former business partners, finding they failed to show how he breached a settlement agreement governin... (more story)
As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompe... (more story)
A few notable transactions marked healthcare dealmaking this past week, as companies bought up assets and inked contracts to expand their portfolios. Here, Law360 breaks down those deals and others from the past week.
Eli Lilly & Co. has come to terms with two clinics that it sued in Washington federal court for trademark infringement after accusing them of tricking customers into thinking they were buying brand name versio... (more story)
Digital Health & Technology More
The U.S. International Trade Commission and U.S. Customs and Border Protection balked at Masimo's request that a D.C. federal court temporarily block a ruling allowing imports of redesigned Apple Watches despi... (more story)
Bankrupt medical technology company UpHealth told a Delaware bankruptcy court that it has reached a settlement resolving Indian company Glocal Healthcare's $200 million adversary proceeding in a bitter feud ov... (more story)
TikTok and its Chinese parent company are taking the state of North Carolina's lawsuit accusing it of intentionally designing the app to addict young users to the state's highest court after a Business Court j... (more story)
The U.S. International Trade Commission has blocked smart ring makers Ultrahuman and RingConn from importing products it found infringed an Ouraring Inc. wearable computing device patent.
Recently released proposed rule amendments to the Colorado Privacy Act that would create some of the most robust protections for minors' online data in the U.S. reflect an ongoing trend of states taking steps ... (more story)
Masimo sued U.S. Customs and Border Protection in D.C. federal court Wednesday, arguing the agency defied the law by issuing a ruling that found a newly redesigned version of Apple's smartwatches is not subjec... (more story)
Policy & Compliance More
The Ninth Circuit refused to revive the Satanic Temple's lawsuit that challenged Idaho's laws criminalizing abortion, ruling in a published amended opinion Tuesday that the religious association of more than 1... (more story)
The Trump administration illegally froze more than $2 billion in grants earmarked for Harvard University when it failed to offer an explanation as to how cutting the funds addressed the government's stated goa... (more story)
An Illinois federal judge has tossed a Teamsters healthcare plan's challenge to an Arkansas insurance regulation that aims to protect local pharmacies from under-reimbursement for prescription drugs, saying th... (more story)
A longtime King & Spalding LLP attorney has brought her healthcare practice to BakerHostetler in Atlanta, the firm announced Wednesday.
The U.S. Department of Justice has intervened in a whistleblower suit against nonprofit nursing home operator ProMedica, alleging a "systematic and pervasive" pattern of understaffing that resulted in "grossly... (more story)
An Arnold & Porter Kaye Scholer LLP team is representing AstraZeneca in its challenge of a Colorado law aimed at guarding the ability of providers to contract with pharmacies for discounted drugs under the 340B program.